|
1
|
Mannuel HD, Mitikiri N, Khan M and Hussain
A: Testicular germ cell tumors: Biology and clinical update. Curr
Opin Oncol. 24:266–271. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nigam M, Aschebrook-Kilfoy B, Shikanov S
and Eggener S: Increasing incidence of testicular cancer in the
United States and Europe between 1992 and 2009. World J Urol.
33:623–631. 2015. View Article : Google Scholar
|
|
3
|
McGlynn KA and Cook MB: Etiologic factors
in testicular germ-cell tumors. Future Oncol. 5:1389–1402. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Koychev D, Oechsle K, Bokemeyer C and
Honecker F: Treatment of patients with relapsed and/or
cisplatin-refractory metastatic germ cell tumours: An update. Int J
Androl. 34:e266–e273. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Palmer RD, Murray MJ, Saini HK, van Dongen
S, Abreu-Goodger C, Muralidhar B, Pett MR, Thornton CM, Nicholson
JC, Enright AJ, et al Children's Cancer and Leukaemia Group:
Malignant germ cell tumors display common microRNA profiles
resulting in global changes in expression of messenger RNA targets.
Cancer Res. 70:2911–2923. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gillis AJ, Stoop HJ, Hersmus R, Oosterhuis
JW, Sun Y, Chen C, Guenther S, Sherlock J, Veltman I, Baeten J, et
al: High-throughput microRNAome analysis in human germ cell
tumours. J Pathol. 213:319–328. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Suh MR, Lee Y, Kim JY, Kim SK, Moon SH,
Lee JY, Cha KY, Chung HM, Yoon HS, Moon SY, et al: Human embryonic
stem cells express a unique set of microRNAs. Dev Biol.
270:488–498. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Voorhoeve PM, le Sage C, Schrier M, Gillis
AJ, Stoop H, Nagel R, Liu YP, van Duijse J, Drost J, Griekspoor A,
et al: A genetic screen implicates miRNA-372 and miRNA-373 as
oncogenes in testicular germ cell tumors. Cell. 124:1169–1181.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Özata DM, Li X, Lee L, Liu J, Warsito D,
Hajeri P, Hultman I, Fotouhi O, Marklund S, Ährlund-Richter L, et
al: Loss of miR-514a-3p regulation of PEG3 activates the NF-kappa B
pathway in human testicular germ cell tumors. Cell Death Dis. In
press.
|
|
11
|
Chiaretti S, Messina M, Tavolaro S, Zardo
G, Elia L, Vitale A, Fatica A, Gorello P, Piciocchi A, Scappucci G,
et al: Gene expression profiling identifies a subset of adult
T-cell acute lymphoblastic leukemia with myeloid-like gene features
and over-expression of miR-223. Haematologica. 95:1114–1121. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Manikandan M, Deva Magendhra Rao AK,
Arunkumar G, Manickavasagam M, Rajkumar KS, Rajaraman R and
Munirajan AK: Oral squamous cell carcinoma: microRNA expression
profiling and integrative analyses for elucidation of
tumourigenesis mechanism. Mol Cancer. 15:282016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mavrakis KJ, Van Der Meulen J, Wolfe AL,
Liu X, Mets E, Taghon T, Khan AA, Setty M, Rondou P, Vandenberghe
P, et al: A cooperative microRNA-tumor suppressor gene network in
acute T-cell lymphoblastic leukemia (T-ALL). Nat Genet. 43:673–678.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kurashige J, Watanabe M, Iwatsuki M,
Kinoshita K, Saito S, Hiyoshi Y, Kamohara H, Baba Y, Mimori K and
Baba H: Overexpression of microRNA-223 regulates the ubiquitin
ligase FBXW7 in oesophageal squamous cell carcinoma. Br J Cancer.
106:182–188. 2012. View Article : Google Scholar :
|
|
15
|
Li J, Guo Y, Liang X, Sun M, Wang G, De W
and Wu W: MicroRNA-223 functions as an oncogene in human gastric
cancer by targeting FBXW7/hCdc4. J Cancer Res Clin Oncol.
138:763–774. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Welcker M and Clurman BE: FBW7 ubiquitin
ligase: A tumour suppressor at the crossroads of cell division,
growth and differentiation. Nat Rev Cancer. 8:83–93. 2008.
View Article : Google Scholar
|
|
17
|
Wang L, Ye X, Liu Y, Wei W and Wang Z:
Aberrant regulation of FBW7 in cancer. Oncotarget. 5:2000–2015.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mizuno Y, Gotoh A, Kamidono S and Kitazawa
S: Establishment and characterization of a new human testicular
germ cell tumor cell line (TCam-2). Nippon Hinyokika Gakkai Zasshi.
84:1211–1218. 1993.In Japanese.
|
|
19
|
Andrews PW, Goodfellow PN, Shevinsky LH,
Bronson DL and Knowles BB: Cell-surface antigens of a clonal human
embryonal carcinoma cell line: Morphological and antigenic
differentiation in culture. Int J Cancer. 29:523–531. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Petrocca F, Visone R, Onelli MR, Shah MH,
Nicoloso MS, de Martino I, Iliopoulos D, Pilozzi E, Liu CG, Negrini
M, et al: E2F1-regulated microRNAs impair TGFbeta-dependent
cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell.
13:272–286. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li X, Zhang Y, Zhang H, Liu X, Gong T, Li
M, Sun L, Ji G, Shi Y, Han Z, et al: miRNA-223 promotes gastric
cancer invasion and metastasis by targeting tumor suppressor
EPB41L3. Mol Cancer Res. 9:824–833. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gottardo F, Liu CG, Ferracin M, Calin GA,
Fassan M, Bassi P, Sevignani C, Byrne D, Negrini M, Pagano F, et
al: Micro-RNA profiling in kidney and bladder cancers. Urol Oncol.
25:387–392. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bloomston M, Frankel WL, Petrocca F,
Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C and Croce
CM: MicroRNA expression patterns to differentiate pancreatic
adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA.
297:1901–1908. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu J, Yao Q, Hou Y, Xu M, Liu S, Yang L,
Zhang L and Xu H: MiR-223/Ect2/p21 signaling regulates osteosarcoma
cell cycle progression and proliferation. Biomed Pharmacother.
67:381–386. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fazi F, Racanicchi S, Zardo G, Starnes LM,
Mancini M, Travaglini L, Diverio D, Ammatuna E, Cimino G, Lo-Coco
F, et al: Epigenetic silencing of the myelopoiesis regulator
microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell. 12:457–466.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Karakatsanis A, Papaconstantinou I,
Gazouli M, Lyberopoulou A, Polymeneas G and Voros D: Expression of
microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c,
miR-221, miR-222, and miR-223 in patients with hepatocellular
carcinoma or intrahepatic cholangiocarcinoma and its prognostic
significance. Mol Carcinog. 52:297–303. 2013. View Article : Google Scholar
|
|
27
|
Mansour MR, Sanda T, Lawton LN, Li X,
Kreslavsky T, Novina CD, Brand M, Gutierrez A, Kelliher MA,
Jamieson CH, et al: The TAL1 complex targets the FBXW7 tumor
suppressor by activating miR-223 in human T cell acute
lymphoblastic leukemia. J Exp Med. 210:1545–1557. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liang H, Yan X, Pan Y, Wang Y, Wang N, Li
L, Liu Y, Chen X, Zhang CY, Gu H, et al: MicroRNA-223 delivered by
platelet-derived microvesicles promotes lung cancer cell invasion
via targeting tumor suppressor EPB41L3. Mol Cancer. 14:582015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
McGirt LY, Adams CM, Baerenwald DA,
Zwerner JP, Zic JA and Eischen CM: miR-223 regulates cell growth
and targets proto-oncogenes in mycosis fungoides/cutaneous T-cell
lymphoma. J Invest Dermatol. 134:1101–1107. 2014. View Article : Google Scholar :
|
|
30
|
Kurozumi A, Goto Y, Matsushita R, Fukumoto
I, Kato M, Nishikawa R, Sakamoto S, Enokida H, Nakagawa M, Ichikawa
T, et al: Tumor-suppressive microRNA-223 inhibits cancer cell
migration and invasion by targeting ITGA3/ITGB1 signaling in
prostate cancer. Cancer Sci. 107:84–94. 2016. View Article : Google Scholar
|
|
31
|
Streppel MM, Pai S, Campbell NR, Hu C,
Yabuuchi S, Canto MI, Wang JS, Montgomery EA and Maitra A: MicroRNA
223 is upregulated in the multistep progression of Barrett's
esophagus and modulates sensitivity to chemotherapy by targeting
PARP1. Clin Cancer Res. 19:4067–4078. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhou X, Jin W, Jia H, Yan J and Zhang G:
MiR-223 promotes the cisplatin resistance of human gastric cancer
cells via regulating cell cycle by targeting FBXW7. J Exp Clin
Cancer Res. 34:282015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Eto K, Iwatsuki M, Watanabe M, Ishimoto T,
Ida S, Imamura Y, Iwagami S, Baba Y, Sakamoto Y, Miyamoto Y, et al:
The sensitivity of gastric cancer to trastuzumab is regulated by
the miR-223/FBXW7 pathway. Int J Cancer. 136:1537–1545. 2015.
View Article : Google Scholar
|
|
34
|
Kumar V, Palermo R, Talora C, Campese AF,
Checquolo S, Bellavia D, Tottone L, Testa G, Miele E, Indraccolo S,
et al: Notch and NF-κB signaling pathways regulate miR-223/FBXW7
axis in T-cell acute lymphoblastic leukemia. Leukemia.
28:2324–2335. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li R, Wu S, Chen X, Xu H, Teng P and Li W:
miR-223/FBW7 axis regulates doxorubicin sensitivity through
epithelial mesenchymal transition in non-small cell lung cancer. Am
J Transl Res. 8:2512–2524. 2016.PubMed/NCBI
|
|
36
|
Akhoondi S, Sun D, von der Lehr N,
Apostolidou S, Klotz K, Maljukova A, Cepeda D, Fiegl H, Dafou D,
Marth C, et al: FBXW7/hCDC4 is a general tumor suppressor in human
cancer. Cancer Res. 67:9006–9012. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rajagopalan H, Jallepalli PV, Rago C,
Velculescu VE, Kinzler KW, Vogelstein B and Lengauer C:
Inactivation of hCDC4 can cause chromosomal instability. Nature.
428:77–81. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mao JH, Perez-Losada J, Wu D, Delrosario
R, Tsunematsu R, Nakayama KI, Brown K, Bryson S and Balmain A:
Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor
gene. Nature. 432:775–779. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kanatsu-Shinohara M, Onoyama I, Nakayama
KI and Shinohara T: Skp1-Cullin-F-box (SCF)-type ubiquitin ligase
FBXW7 negatively regulates spermatogonial stem cell self-renewal.
Proc Natl Acad Sci USA. 111:8826–8831. 2014. View Article : Google Scholar : PubMed/NCBI
|
